Drugs & Targets Ukoniq receives FDA accelerated approval for marginal zone lymphoma and follicular lymphoma February 12, 2021Vol.47 No.06
Drugs & Targets Breyanzi receives FDA approval for adults with relapsed or refractory large-B-cell lymphoma February 12, 2021Vol.47 No.06
Drugs & Targets Libtayo receives FDA approval as first immunotherapy for patients with advanced basal cell carcinoma February 12, 2021Vol.47 No.06
Drugs & Targets MD Anderson, Mirati Therapeutics collaborate on KRAS and solid tumor research February 12, 2021Vol.47 No.06
Drugs & Targets Inrebic received European Commission approval for myelofibrosis February 12, 2021Vol.47 No.06
Clinical Roundup ASCO, Friends of Cancer Research recommend broadening eligibility criteria in cancer clinical trials February 12, 2021Vol.47 No.06
Funding Opportunities DOD ovarian cancer research funding opportunity for FY21 February 12, 2021Vol.47 No.06
Funding Opportunities DOD lung cancer research funding opportunity for FY21 February 12, 2021Vol.47 No.06
In Brief Anne Chiang named deputy chief medical officer and chief integration officer at Smilow Cancer Hospital February 12, 2021Vol.47 No.06
